TNDM
Tandem Diabetes CareDNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-21
Current thesis
Tandem sustains strong t:slim X2/Control‑IQ adoption, expands recurring software revenue, and improves margins — driving >50% upside as adoption accelerates and investor confidence returns.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -19.4.
What can break
Regulatory setbacks, an adverse recall, or persistent margin pressure from pricing and reimbursement could erase current value and push shares substantially lower (~40%+ decline).
Momentum
9
Value
37
Sentiment
72
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $22.80 · Bull $33.17 · Bear $12.44
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-27 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $29.85
Why
Momentum9 · Δ7d +3.4
Value37 · Δ7d 0.0
Sentiment72 · Δ7d -19.4
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
9
26% active weight
Current posture
7d trendImproving
Δ7d
+3.4
Δ21d
-1.4
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.2
Sentiment
72
34% active weight
Current posture
7d trendSoftening
Δ7d
-19.4
Δ21d
-22.7
Why this grade
Composite grade D. Momentum 9.1 / Value 36.5 / Sentiment 72.0
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$1.21B
Beta
1.69
Shares Out
68.53M
P/E (TTM) · Derived
-5.8
P/S (TTM)
1.56
P/FCF (TTM) · Derived
-309.31
Rev YoY
+5.5%
EPS YoY
-84.8%
Gross Margin
+54.9%
Op Margin
-19.5%
Net Debt
$156.71M
Current Ratio
3.58
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology